Pharmacophore an International Research Journal
Pharmacophore
Submit Manuscript
Open Access | Published: 2019 - Issue 6

A Comparative Study of The Effect of Crude and Nanoparticles Costus Speciosus On Testicular Damage Associated to Experimentally Induced Type 2 Diabetes ‎‎ ‎ Download PDF


Safia M. Bahshwan, Samar O. Abdullah Rabah, Arwa M. Turkistani
Abstract

Background: Diabetes mellitus is linked with many macrovascular and microvascular complications including cardiovascular, neuro, eye, kidney, liver, and reproductive injuries. Both clinical and animal research disclosed deterioration of spermatogenesis, decreased sperm count, seminal fluid volume, sperm motility, and depressed testosterone concentrations during diabetes. Nanotechnology employment in the alternative medicine field is one of the rapidly rising areas. Objective: To investigate the therapeutic effect of crude, nanoparticles (NPs) Costus speciosus (C. speciosus), and metformin against type 2 diabetes. In addition, their role in treating diabetes-induced testicular toxicity was investigated. Material and Methods: Diabetes was induced by feeding the rats with a high-fat diet (HFD) for 2 weeks followed by single i.p. injection of STZ at a dose of 45 mg/kg. Two weeks after STZ injection, crude (500 mg/kg) and NPs C. speciosus (250 mg/kg) and metformin (200 mg/kg) were administered daily by gavage for a period of 8 weeks. Results: Only NPs C. speciosus significantly decreased serum glucose levels versus diabetic rats. The hypoglycemic effect of NPs C. speciosus was similar to the metformin effect and superior to crude C. speciosus. All treatment regimens significantly increased % body weight gain than diabetic rats. All regimens significantly increased serum insulin and testosterone levels. Concerning testosterone crude C. speciosus is superior to NPs C. speciosus an effect confirmed with the histopathological findings. Conclusion: A lower dose of NPs C. speciosus significantly ameliorated diabetes-induced hyperglycemia, body-weight loss, and testicular damage‎‎‎‎.

QR code:

Short Link:
Quick Access

Associations

Pharmacophore
ISSN: 2229-5402

Copyright © 2024 Pharmacophore. Authors retain copyright of their article if they are accepted for publication.
Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.